ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 411 filers reported holding ENCOMPASS HEALTH CORP in Q4 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $374,786 | +6.2% | 5,580 | +7.1% | 0.04% | 0.0% |
| Q2 2023 | $352,789 | +14.4% | 5,210 | -8.6% | 0.04% | +10.8% |
| Q1 2023 | $308,266 | -6.6% | 5,698 | +3.3% | 0.04% | -9.8% |
| Q4 2022 | $329,877 | +28.4% | 5,515 | -2.8% | 0.04% | +17.1% |
| Q3 2022 | $257,000 | -17.6% | 5,675 | +2.0% | 0.04% | -12.5% |
| Q2 2022 | $312,000 | -24.1% | 5,564 | -3.7% | 0.04% | -14.9% |
| Q1 2022 | $411,000 | +24.5% | 5,779 | +14.4% | 0.05% | +20.5% |
| Q4 2021 | $330,000 | +41.6% | 5,052 | +62.5% | 0.04% | +25.8% |
| Q3 2021 | $233,000 | -10.0% | 3,108 | -6.3% | 0.03% | -13.9% |
| Q2 2021 | $259,000 | -27.7% | 3,317 | -24.2% | 0.04% | -40.0% |
| Q1 2021 | $358,000 | +9.8% | 4,375 | +11.1% | 0.06% | -3.2% |
| Q4 2020 | $326,000 | +24.9% | 3,938 | -2.1% | 0.06% | +3.3% |
| Q3 2020 | $261,000 | +4.0% | 4,022 | -0.6% | 0.06% | -3.2% |
| Q2 2020 | $251,000 | +3.7% | 4,046 | +7.1% | 0.06% | -13.9% |
| Q1 2020 | $242,000 | +18.6% | 3,779 | +28.1% | 0.07% | +44.0% |
| Q4 2019 | $204,000 | – | 2,949 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
| Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
| Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
| DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
| Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
| Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
| GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
| CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
| EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
| S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |